104 related articles for article (PubMed ID: 7061110)
1. Isolation and characterization of the C3b-binding entity of C3b-receptor from human erythrocytes.
Mussel HH; Ehlen T; Schmitt M; Kazatchkine MD; Neyses L; Dierich MP
Immunol Lett; 1982 Jan; 4(1):1-6. PubMed ID: 7061110
[TBL] [Abstract][Full Text] [Related]
2. C3 modified at the thiolester site: acquisition of reactivity with cellular C3b receptors.
Schreiber RD; Pangburn MK; Müller-Eberhard HJ
Biosci Rep; 1981 Nov; 1(11):873-80. PubMed ID: 6458338
[TBL] [Abstract][Full Text] [Related]
3. Physicochemical characterization of C3b receptors isolated from human erythrocytes by immunoprecipitation.
Gerdes J; Stein H
Immunology; 1980 Dec; 41(4):929-36. PubMed ID: 7461716
[TBL] [Abstract][Full Text] [Related]
4. Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte.
Fearon DT
J Exp Med; 1980 Jul; 152(1):20-30. PubMed ID: 6967510
[TBL] [Abstract][Full Text] [Related]
5. Role of beta 1H for the binding of C3b-coated particles to human lymphoid and phagocytic cells.
Schmitt M; Mussel HH; Hammann KP; Scheiner O; Dierich MP
Eur J Immunol; 1981 Oct; 11(10):739-45. PubMed ID: 6458499
[TBL] [Abstract][Full Text] [Related]
6. Regulatory proteins for the activated third and fourth components of complement (C3b and C4b) in mice. II. Identification and properties of complement receptor type 1 (CR1).
Kinoshita T; Lavoie S; Nussenzweig V
J Immunol; 1985 Apr; 134(4):2564-70. PubMed ID: 3156184
[TBL] [Abstract][Full Text] [Related]
7. Human complement (C3b) receptors defined by a mouse monoclonal antibody.
Gerdes J; Naiem M; Mason DY; Stein H
Immunology; 1982 Apr; 45(4):645-53. PubMed ID: 7068171
[TBL] [Abstract][Full Text] [Related]
8. Action of the C3b-inactivator on the cell-bound C3b.
Law SK; Fearon DT; Levine RP
J Immunol; 1979 Mar; 122(3):759-65. PubMed ID: 448074
[TBL] [Abstract][Full Text] [Related]
9. Description of a simple, specific, and sensitive test for the detection of detergent-solubilized C3b receptor.
Dierich MP; Ehlen T; Mussel HH
Immunobiology; 1981; 160(2):241-7. PubMed ID: 7319543
[TBL] [Abstract][Full Text] [Related]
10. Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes.
Medof ME; Iida K; Mold C; Nussenzweig V
J Exp Med; 1982 Dec; 156(6):1739-54. PubMed ID: 7175439
[TBL] [Abstract][Full Text] [Related]
11. Identification of a C3bi-specific membrane complement receptor that is expressed on lymphocytes, monocytes, neutrophils, and erythrocytes.
Ross GD; Lambris JD
J Exp Med; 1982 Jan; 155(1):96-110. PubMed ID: 6915077
[TBL] [Abstract][Full Text] [Related]
12. Importance of factors H and I for the adherence of C3b-coated erythrocytes to cells.
Scheiner O; Schulz TF; Schmid HU; Lambris JD; Alsenz J; Dierich MP
Immunobiology; 1983 Aug; 165(2):211-24. PubMed ID: 6226591
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of C3b receptors on human lymphocytes, phagocytes, erythrocytes and renal glomerulus cells by monoclonal antibodies.
Dierich MP; Mussel HH; Scheiner O; Ehlen T; Burger R; Peters H; Schmitt M; Trepke S; Zimmer G
Immunology; 1982 Jan; 45(1):85-96. PubMed ID: 7056569
[TBL] [Abstract][Full Text] [Related]
14. [Immune adherence (C3b) receptor activity of erythrocytes in patients with esophageal cancer and cancer of the gastric cardia].
Cai FQ; Jing YH; Gao YF; Yang XW; Li FZ; Zhao LQ; Xiong ML
Zhonghua Zhong Liu Za Zhi; 1986 Jul; 8(4):253-5. PubMed ID: 2944730
[TBL] [Abstract][Full Text] [Related]
15. Complement receptors on guinea pig epidermal Langerhans cells.
Berman B; Gigli I
J Immunol; 1980 Feb; 124(2):685-90. PubMed ID: 7356709
[TBL] [Abstract][Full Text] [Related]
16. Role of binding through C3b and IgG in polymorphonuclear neutrophil function: studies with trypsin-generated C3b.
Newman SL; Johnston RB
J Immunol; 1979 Oct; 123(4):1839-46. PubMed ID: 573303
[No Abstract] [Full Text] [Related]
17. Studies on immune adherence (C3b) receptor activity of human erythrocytes: relationship between receptor activity and presence of immune complexes in serum.
Inada Y; Kamiyama M; Kanemitsu T; Hyman CL; Clark WS
Clin Exp Immunol; 1982 Oct; 50(1):189-97. PubMed ID: 6216998
[TBL] [Abstract][Full Text] [Related]
18. Complement receptor binding of C3b-coated cells treated with C3b inactivator, beta 1H globulin and trypsin.
Carlo JR; Ruddy S; Studer EJ; Conrad DH
J Immunol; 1979 Aug; 123(2):523-8. PubMed ID: 88474
[TBL] [Abstract][Full Text] [Related]
19. Xenoantiserum to human C3 receptors: its preparation and effect on the C3b and C3d receptors of tonsil cells and the C3b receptors of erythrocytes and neutrophils.
Gerdes J; Klatt U; Stein H
Immunology; 1980 Jan; 39(1):75-84. PubMed ID: 6991397
[TBL] [Abstract][Full Text] [Related]
20. Demonstration of C3b receptor-like activity and of decay-accelerating factor-like activity on rabbit erythrocytes.
Horstmann RD; Müller-Eberhard HJ
Eur J Immunol; 1986 Sep; 16(9):1069-73. PubMed ID: 2428623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
